Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats
Toshio Nishikimi(Kyoto University), Hiroaki Matsuoka(Social Welfare Department), Xin Wang(Wannan Medical College), Hiroaki Shimokawa(Tohoku University), Hidehiko Ono(Dokkyo Medical University), Yosuke Mori(Dokkyo Medical University), Kazuyoshi Tadokoro(Dokkyo Medical University), Yayoi Ishikawa(Dokkyo Medical University), Kazumi Akimoto(Dokkyo University)
Cited by 88
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578